SXTC
China SXT Pharmaceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
SXTC Filings
Filing Date
Form Description
Form Type
2025-11-17
Form EFFECT - Notice of Effectiveness
2025-11-17 ·
Form EFFECT - Notice of Effectiveness
2025-11-10
Form F-3 - Registration statement by foreign private issuers
2025-11-10 ·
Form F-3 - Registration statement by foreign private issuers
2025-11-10
Form POS AM - Post-Effective amendments for registration statement
2025-11-10 ·
Form POS AM - Post-Effective amendments for registration statement
2025-08-07
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-07 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-07
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-07 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-07
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-07 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-07
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-07 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-07-31
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Financials
2025-07-31 · Financials
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025-07-29
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-07-29 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-07-15
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-07-15 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
